EMA seeks to issue guidance on liver damage from Novartis’ gene therapy Therapeutics The European Medicines Agency said it is asking healthcare providers to conduct liver tests on patients treated with Zolgensma, after recent reports of deaths related to the gene therapy. Read more January 13, 2023/by Reuters Health https://www.pharmalive.com/wp-content/uploads/2022/04/ReutersHealthNovartisbuilding.webp 729 1200 Reuters Health https://www.pharmalive.com/wp-content/uploads/2020/01/Pharmalive_4c-300x37.png Reuters Health2023-01-13 08:32:302023-01-13 09:41:23EMA seeks to issue guidance on liver damage from Novartis' gene therapy
